The Role of Plasmodium falciparum Glutamate Dehydrogenase A in Parasite Development
Author Information
Author(s): Janet Storm, Jan Perner, Isabela Aparicio, Eva-Maria Patzewitz, Kellen Olszewski, Manuel Llinas, Paul C Engel, Sylke Müller
Primary Institution: University of Glasgow
Hypothesis
Is GDHa a suitable drug target during the intra-erythrocytic development of Plasmodium falciparum?
Conclusion
GDHa is not essential for the growth of Plasmodium falciparum and is unlikely to be a suitable target for drug development.
Supporting Evidence
- The absence of GDHa did not affect the growth of the mutant parasites under low or elevated oxygen conditions.
- GDHa null mutants showed no significant changes in the expression of antioxidant proteins.
- Metabolic labeling experiments indicated that GDHa is not essential for the conversion of glutamate to α-ketoglutarate.
Takeaway
The malaria parasite can grow just fine without a specific enzyme called GDHa, which means it might not be a good target for new medicines.
Methodology
The study involved creating GDHa null mutants of P. falciparum and assessing their growth and metabolic functions under various conditions.
Limitations
The study was conducted under in vitro conditions, which may not fully represent the in vivo environment of the parasite.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website